Sonnet BioTherapeutics Holdings, Inc. (SONN) After-Market Surge Spurs Investor Interest

Sonnet BioTherapeutics Holdings, Inc. (SONN) experienced a notable surge in after-market trading on Thursday, with the stock price reaching $1.05, representing a change percentage of 13.02%. The surge, although unattributed to any specific reason, has captured the attention of investors, prompting them to evaluate the investment potential of SONN stock. Financial Results and Cash Position […]

Market Globalist
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.